Where to get cervical cancer vaccine in China

The HPV vaccine has attracted widespread attention since the day it was announced that it could be administered in China. At present, there is only a bivalent vaccine on the market in my country, which is only suitable for women. So where can I get the HPV vaccine in China?

1. Cervical cancer has long become the leading killer of women's reproductive health. Especially those sexually active women are at a greater risk of infection with the carcinogen HPV. If they are unfortunately infected with this pathogen, they may develop cervical cancer. There are age limits for HPV vaccination, but these limits are not absolute. The key is whether you have sexual life. This type of vaccine is most effective only for women who have no sexual history. The HPV vaccine can only be used for prevention and has no informative effect on patients infected with related viruses.

2. Now, the first batch of imported vaccines have passed my country's quality inspection and are supplied to all provinces of China. Vaccines can be obtained at community health services and community health service stations in major cities. This takes into account the health needs of Chinese women for this type of vaccine.

3. However, the policies of various provinces and cities are different, and the final cost of vaccination may also be different. According to relevant regulations, the total price for all vaccinations is 174 yuan.

Is it true that vaccination is a permanent solution?

The current HPV vaccine cannot protect against all types of HPV viruses, but can only protect against the types of viruses that are most likely to cause cervical cancer. Vaccine injection can reduce the risk of cervical cancer, but it cannot prevent cervical cancer 100%.

Will bivalent vaccines be included in medical insurance coverage in the future?

According to statistics, although 58 countries around the world have included cervical cancer vaccination in government subsidies, relevant plans have not yet been established in my country. Zhao Fanghui, director of the office of the Clinical Epidemiology Department of Outpatient Tumors at the Cancer Hospital of the Chinese Academy of Medical Sciences, professor and doctoral supervisor, said that my country is currently carrying out basic research and development of HPV vaccines, and one or two are already in clinical trials. In the future, more vaccines will be allowed to enter the market. According to market demand, the price of HPV vaccines will drop, and may then be included in medical insurance.